Drug Database
Back to search

Netherlands· NL-9ccaa6f1d126

Sigmopan 10 mg filmomhulde tabletten

A butylscopolamine product containing hyoscinebutylbromide, registered in Netherlands by RIA Generics Limited. The same ATC class is registered in 11 of our 19 countries.

ATC A03BB01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSigmopan 10 mg filmomhulde tablettenATCA03BB01REGISTER NO.NL-9ccaa6f1d126PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about hyoscinebutylbromideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Butylscopolamine is registered in 11 of 19 countries.

Countries holding a registration under ATC A03BB01 (butylscopolamine), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 6 of them publish a price we can compare per daily dose
Search butylscopolamine products by name

Butylscopolamine · ATC A03BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HYOSCINEBUTYLBROMIDE
Manufacturer
RIA Generics Limited
Country
Netherlands (NL)
ATC code
A03BB01
ATC class
Butylscopolamine
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    129760

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Butylscopolamine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All butylscopolamine products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Buscapina, Buscopan
  • Belgium · Buscopan, Buscopan Forte
  • Bulgaria · Бусколизин, Бусколизин Форте
  • Cyprus · Avotrin, Buscopan
  • Czechia · Buscopan, Butylskopolaminium Bromid Kalceks
  • Germany · Buscopan, Buscopan Ampullen
  • Denmark · Bumacor
  • Estonia · Bysimin
  • Spain · Buscapina, Buscopresc
  • Finland · Bumacor, Buscopan
  • France · Buscopan, Scoburen
  • United Kingdom (Northern Ireland) · Almus Ibs Relief, Almus Stomach Cramp Relief
  • Greece · Avotrin, Buscopan
  • Croatia · Buscopan, Bysimin
  • Hungary · Buscopan, Buscopan Forte
  • Ireland · Buscopan, Buscopan Ampoules
  • Italy · Addofix, Buscopan
  • Luxembourg · Buscopan, Buscopan Forte
  • Latvia · Buscopan, Hyoscine Butylbromide Kalceks
  • Malta · Buscopan, Buscopan Ampoules
  • Norway · Bumacor, Buscopan
  • Poland · Aurogastro, Buscolysin
  • Portugal · Buscopan, Butilescopolamina Conforpam
  • Romania · Buscopan, Buscotil
  • Sweden · Bumacor, Buscopan
  • Slovenia · Buscopan
  • Slovakia · Buscopan, Scopolamine Butylbromide Kalceks

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4d31708d-7c4c-446a-b000-46050722e80b
GET /v1/drugs/4d31708d-7c4c-446a-b000-46050722e80b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129760_smpc.pdf",
  "strength": null,
  "atc_label": "Butylscopolamine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129760",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "LACTOSE 1-WATER",
    "MACROGOL 3000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POLYVINYLALCOHOL, GEDEELTELIJK GEHYDROLYSEERD (E1203)",
    "TALK (E 553b)",
    "TITAANDIOXIDE (E 171)",
    "WIJNSTEENZUUR, (L (+) Vorm) (E 334)"
  ],
  "substances": [
    "HYOSCINEBUTYLBROMIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129760.pdf",
  "authorised_at": "2022/09/22",
  "procedure_number": "NL/H/6045/001",
  "dispensing_status": "Uitsluitend apotheek of drogist",
  "registration_number": "129760",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about butylscopolamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console